{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:27:48Z","timestamp":1769182068236,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84413-0","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T03:49:06Z","timestamp":1735876146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Yi-Jie","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Sing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou-Wu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Hsin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szu-Chia","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Chun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng-Yu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsai-Chung","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"issue":"10381","key":"84413_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","volume":"401","author":"WJ Jeng","year":"2023","unstructured":"Jeng, W. J., Papatheodoridis, G. V. & Lok, A. S. F. Hepatitis B. Lancet 401(10381), 1039\u20131052 (2023).","journal-title":"Lancet"},{"issue":"1","key":"84413_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7326\/0003-4819-147-1-200707030-00010","volume":"147","author":"CL Lai","year":"2007","unstructured":"Lai, C. L. & Yuen, M. F. The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points. Ann. Intern. Med. 147(1), 58\u201361 (2007).","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"84413_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261878","volume":"16","author":"T Suzuki","year":"2021","unstructured":"Suzuki, T. et al. Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection. PLoS One. 16(12), e0261878 (2021).","journal-title":"PLoS One."},{"key":"84413_CR4","unstructured":"World Health Organization. Hepatitis B. 2023; https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed Aug 10, 2023."},{"issue":"9","key":"84413_CR5","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1016\/j.cgh.2020.01.018","volume":"18","author":"ML Chang","year":"2020","unstructured":"Chang, M. L., Cheng, J. S., Chien, R. N. & Liaw, Y. F. Hepatitis flares are associated with better outcomes than no flare in patients with decompensated cirrhosis and chronic hepatitis B virus infection. Clin. Gastroenterol. Hepatol. 18(9), 2064-2072.e2062 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"84413_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jhep.2012.02.033","volume":"57","author":"CY Peng","year":"2012","unstructured":"Peng, C. Y., Chien, R. N. & Liaw, Y. F. Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy. J. Hepatol. 57(2), 442\u2013450 (2012).","journal-title":"J. Hepatol."},{"issue":"10","key":"84413_CR7","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.jfma.2020.07.003","volume":"119","author":"CL Lin","year":"2020","unstructured":"Lin, C. L., Tseng, K. C., Chen, K. Y., Liao, L. Y. & Kao, J. H. Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy. J. Formos. Med. Assoc. 119(10), 1483\u20131489 (2020).","journal-title":"J. Formos. Med. Assoc."},{"issue":"4","key":"84413_CR8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/jgh.13213","volume":"31","author":"Shalimar","year":"2016","unstructured":"Shalimar, et al. Acute on chronic liver failure because of acute hepatic insults: Etiologies, course, extrahepatic organ failure and predictors of mortality. J. Gastroenterol. Hepatol. 31(4), 856\u2013864 (2016).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"84413_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","volume":"13","author":"SK Sarin","year":"2019","unstructured":"Sarin, S. K. et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol. Int. 13(4), 353\u2013390 (2019).","journal-title":"Hepatol. Int."},{"issue":"12","key":"84413_CR10","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1136\/gutjnl-2017-314641","volume":"67","author":"T Wu","year":"2018","unstructured":"Wu, T. et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut. 67(12), 2181\u20132191 (2018).","journal-title":"Gut."},{"issue":"1","key":"84413_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin, S. K. et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol. Int. 10(1), 1\u201398 (2016).","journal-title":"Hepatol. Int."},{"issue":"2","key":"84413_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"P Lampertico","year":"2017","unstructured":"Lampertico, P. et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol. 67(2), 370\u2013398 (2017).","journal-title":"J. Hepatol."},{"issue":"4","key":"84413_CR13","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault, N. A. et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 67(4), 1560\u20131599 (2018).","journal-title":"Hepatology."},{"issue":"4","key":"84413_CR14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s12072-022-10357-0","volume":"16","author":"KC Lee","year":"2022","unstructured":"Lee, K. C., Cheng, J. S., Chang, M. L., Chien, R. N. & Liaw, Y. F. Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study. Hepatol. Int. 16(4), 799\u2013806 (2022).","journal-title":"Hepatol. Int."},{"issue":"6","key":"84413_CR15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.jhep.2005.01.019","volume":"42","author":"TI Huo","year":"2005","unstructured":"Huo, T. I. et al. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J. Hepatol. 42(6), 826\u2013832 (2005).","journal-title":"J. Hepatol."},{"issue":"12","key":"84413_CR16","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.cgh.2018.04.063","volume":"16","author":"JW Jang","year":"2018","unstructured":"Jang, J. W. et al. Effects of virologic response to treatment on short- and long-term outcomes of patients with chronic hepatitis B virus infection and decompensated cirrhosis. Clin. Gastroenterol. Hepatol. 16(12), 1954-1963.e1953 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"9","key":"84413_CR17","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/jgh.15007","volume":"35","author":"TC Yip","year":"2020","unstructured":"Yip, T. C. et al. Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B. J. Gastroenterol. Hepatol. 35(9), 1610\u20131618 (2020).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"84413_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.910549","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. Hepatitis b virus reactivation increased the risk of developing hepatic failure and mortality in cirrhosis with acute exacerbation. Front. Microbiol. 13, 910549 (2022).","journal-title":"Front. Microbiol."},{"issue":"1","key":"84413_CR19","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1186\/s12879-021-06974-z","volume":"21","author":"J Liang","year":"2021","unstructured":"Liang, J. et al. Hepatitis B-related acute-on-chronic liver failure induced by hepatotropic viral insult is associated with worse prognosis than that induced by non-virus insult. BMC Infect. Dis. 21(1), 1273 (2021).","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"84413_CR20","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","volume":"130","author":"UH Iloeje","year":"2006","unstructured":"Iloeje, U. H. et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 130(3), 678\u2013686 (2006).","journal-title":"Gastroenterology."},{"issue":"5","key":"84413_CR21","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1053\/j.gastro.2008.02.075","volume":"134","author":"M Kumar","year":"2008","unstructured":"Kumar, M. et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology. 134(5), 1376\u20131384 (2008).","journal-title":"Gastroenterology."},{"issue":"1","key":"84413_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3350\/cmh.2015.21.1.41","volume":"21","author":"SK Jung","year":"2015","unstructured":"Jung, S. K. et al. Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-na\u00efve and nucleos(t)ide analogue-experienced chronic hepatitis B patients. Clin. Mol. Hepatol. 21(1), 41\u201348 (2015).","journal-title":"Clin. Mol. Hepatol."},{"issue":"5","key":"84413_CR23","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/jgh.12476","volume":"29","author":"WK Seto","year":"2014","unstructured":"Seto, W. K. et al. Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment. J. Gastroenterol. Hepatol. 29(5), 1028\u20131034 (2014).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"84413_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000671","author":"CJ Karvellas","year":"2023","unstructured":"Karvellas, C. J. et al. AASLD Practice guidance on Acute-on-chronic liver failure and the management of critically Ill patients with cirrhosis. Hepatology. https:\/\/doi.org\/10.1097\/HEP.0000000000000671 (2023).","journal-title":"Hepatology."},{"issue":"Suppl 1","key":"84413_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1440-1746.2010.06541.x","volume":"26","author":"CL Lin","year":"2011","unstructured":"Lin, C. L. & Kao, J. H. The clinical implications of hepatitis B virus genotype: Recent advances. J. Gastroenterol. Hepatol. 26(Suppl 1), 123\u2013130 (2011).","journal-title":"J. Gastroenterol. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84413-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84413-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84413-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T14:10:57Z","timestamp":1736259057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84413-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84413"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84413-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"19 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board and Ethics Committee of Taichung Veterans General Hospital (IRB: CE-18232A) and the Ethics Committee waived informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"562"}}